Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on October 5, 2026

AI Security: Every Major AI Model Fails ClawSecure's Test
M2MMA Announces Milestone Month with Global Launch of M2Intel OS
TriCelX Earns AABB Accreditation — Three FDA-Cleared Trials, One Biotherapeutic, One Standard
Free Tool RouterMap Shows UK Homes the Best Place to Put a Wi-Fi Router
One Water Systems Announces 21% Savings on ELITE 15 Whole Home Water Filtration Systems
Frankenstein, a faithful musical film adaptation of Mary Shelley's novel streams on Prime Video and other platforms
INTERNATIONAL SPACE UNIVERSITY LAUNCHES  GLOBAL CAMPUS INITIATIVE
FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026
Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
Satellos Granted Composition of Matter Patent for Forazapadin
Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
DV Launches Attribution Measurement and Advances Brand Suitability for ChatGPT Ads
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
Harrow Closes Acquisition of TYRVAYA®

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.